The AI-enabled data company will integrate ATCOR and CONNEQT’s technology into its platform in early 2023 to monitor maternal health and cardiovascular diseases.
Invaryant and CardieX partner to expand RPM during clinical trials
The AI-enabled data company will integrate ATCOR and CONNEQT’s technology into its platform in early 2023 to monitor maternal health and cardiovascular diseases.
